{"id":"W2057099373","doi":"10.1002/phar.1561","title":"Vedolizumab for the Treatment of Moderately to Severely Active Ulcerative Colitis","year":2015,"lang":"en","type":"review","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Ulcerative colitis; Vedolizumab; Medicine; Inflammatory bowel disease; Adverse effect; Immunology; Population; Immune dysregulation; Disease; Colitis; Immune system; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002797193,0.000477878,0.0007633425,0.00157306,0.0002347767,0.0005026701,0.0005532051,0.0006802606,0.002854215],"category_scores_gemma":[0.0004328183,0.0001386697,0.0004066888,0.00107496,0.0002477215,0.0006120434,0.0003833137,0.001710169,0.001699533],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003939955,"about_ca_system_score_gemma":0.0004893325,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007669525,"about_ca_topic_score_gemma":0.002515848,"domain_scores_codex":[0.9998852,0.00001908521,0.00001797074,0.0000174419,0.00004822533,0.00001198119],"domain_scores_gemma":[0.9998928,0.00004491723,0.00001837334,0.000002905005,0.00002608928,0.00001485678],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007984239,0.00006687974,0.0001407977,0.00752229,0.00007093416,0.0002995279,0.00004415034,0.0001858536,0.001494339,0.001737362,0.03344832,0.9549097],"study_design_scores_gemma":[0.00003940127,0.0001115576,0.001013462,0.002215193,0.0001001379,0.002781855,0.00003257008,0.00007023608,0.0004179209,0.0009730263,0.992232,0.00001264673],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002373118,0.9974774,0.0001383858,0.000329802,0.0002187053,0.000007385943,0.00002068863,0.000009885041,0.001560516],"genre_scores_gemma":[0.001397277,0.9968567,0.0002510374,0.0003219261,0.0001295947,0.000008996761,0.00004069634,0.000001708281,0.0009920193],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002854215,"threshold_uncertainty_score":0.009548366,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05900255429947274,"score_gpt":0.4016657768618087,"score_spread":0.3426632225623359,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}